Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
Covid19-Sources
Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 ...
Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater
Eric Feigl-Ding on Twitter
Viren sind nicht das Problem-bleiben Sie besonnen!
How Bad is my Batch ?
Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders
Rates of asymptomatic respiratory virus infection across age groups
Does Influenza Transmission Occur from Asymptomatic Infection or Prior to Symptom Onset?
Debunked, the myth of asymptomatic Covid transmission
Typ-1-Diabetes: Mehr Fälle bei Kindern in Corona-Pandemie
Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant | NEJM
Israeli study offers strongest proof yet of vitamin D’s power to fight COVID
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge
‘Pandemic of the unboosted’: low US Covid jab uptake piles pressure on hospitals
Neutralization profile of Omicron variant convalescent individuals
Limited cross-variant immunity after infection with the SARS-CoV-2 Omicron variant without vaccination
COVID-19 reinfections among naturally infected and vaccinated individuals
Non-cell autonomous disruption of nuclear architecture as a potential cause of COVID-19 induced anosmia
Coronavirus (COVID-19) Infection Survey, characteristics of people testing positive for COVID-19, UK - Office for National Statistics
Face mask fit hacks: Improving the fit of KN95 masks and surgical masks with fit alteration techniques
Paper demonstrating Omicron's immune escape vs. vaccination and previous infection
Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households
In rare cases, coronavirus vaccines may cause Long Covid–like symptoms
German scientists researching nasal spray COVID vaccination
%2Fcloudfront-us-east-2.images.arcpublishing.com%2Freuters%2FTHVEYKGLTRO2VEGBZ6S4RQRINM.jpg?width=92&height=&ar=&mode=&format=avif&dpr=2)
Easier to produce COVID vaccine shows promise in trials; nasal spray vaccine booster works in mice
Bharat Biotech seeks nod for phase-3 clinical trials of nasal vaccine
Historically High Excess Mortality During the COVID-19 Pandemic in Switzerland, Sweden, and Spain
Even More Safety and Effectiveness Data for COVID-19 Vaccines for Children
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants